Whitfield B. Growdon, MD
Assistant Professor
Massachusetts General Hospital/Harvard University
One Charles Street South
Boston,
MA
USA
02115
Biographical Sketch: Whitfield Growdon is GYN Oncology faculty and spends 75% of his time as a basic science researcher with a K12 grant to investigate molecular signatures in endometrial cancer. He has published on mutational signatures in rare high grade endometrial cancers.
Papers:
74
Recent trends in the utilization of lymphadenectomy among patients undergoing surgery for endometrioid adenocarcinoma of the endometrium: an analysis of the Surveillance, Epidemiology, and End Results database, 1998-2010
81
The impact of adjuvant therapy on survival in uterine clear cell carcinoma patients
150
PI3K coupled to PARP inhibition demonstrates synergistic anti-tumor activity in endometrioid endometrial cancer patient derived xenografts
189
The impact of body mass index on intraperitoneal chemotherapy outcomes
224
Impact of venous thromboembolism on mortality of elderly medicare patients with epithelial endometrial cancer
241
Comparing vaginal sarcoma and carcinoma in the Surveillance, Epidemiology and End Results program, 1988 to 2010: an analysis of 4,062 patients
392
Next-generation sequencing demonstrates genomic signature of resistance patterns following phosphatidylinositol 3-kinase (PI3K) inhibition
406
Comparing the natural history and survival of vulvar sarcoma and squamous cell carcinoma: an analysis 11,677 cases in the Surveillance, Epidemiology, and End Results database
409
Gynecologic oncologist as surgical consultant: intraoperative consultations during general gynecologic surgery as an important focus of gynecologic oncology training
424
Comparing survival of vulvar melanoma and squamous cell carcinoma: an analysis of 13,112 patients in the Surveillance, Epidemiology and End Results database